Companies and People News for November 2009

Companies and People News Archive

Private sector urged to seize opportunity and back Research Council commitment to bioprocessing R&D Private sector urged to seize opportunity and back Research Council commitment to bioprocessing R&D

Private industry has been urged to join a public sector commitment to fund advanced manufacturing research and development in bioprocessing.

MedImmune announces winners of first European cancer research abstract competition MedImmune announces winners of first European cancer research abstract competition

MedImmune has announced the winners of its European research abstract competition, which highlights the work of tomorrow's budding scientific leaders in cancer research.

Visions of Discovery: a celebration of research images Visions of Discovery: a celebration of research images

'Visions of Discovery', a new exhibition featuring stunning images arising from biological and medical research, has opened at the University of Dundee.

Astex announces strategic drug discovery alliance with GlaxoSmithKline Astex announces strategic drug discovery alliance with GlaxoSmithKline

Astex Therapeutics Limited announced recently that it has entered into a new collaboration agreement with GlaxoSmithKline (GSK) to discover, develop and commercialize novel compounds directed against multiple therapeutic targets of interest to GSK.

GSM Association and the University of Manchester to establish an m-Health Innovation Centre GSM Association and the University of Manchester to establish an m-Health Innovation Centre

The GSM Association today announced that it has signed a Memorandum of Understanding with the University of Manchester to establish an m-Health Innovation Centre in Manchester, which will act as a UK focus for m-Health activity.

Astex announces a CRADA with the National Cancer Institute for its HSP90 inhibitor AT13387 Astex announces a CRADA with the National Cancer Institute for its HSP90 inhibitor AT13387

Astex Therapeutics Limited recently announced the signing of a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute to collaborate on the study of its novel small-molecule HSP90 inhibitor, AT13387, for the treatment of cancer.